Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
OPTIMIZE was a randomized, open label study, which included 330 patients with chronic kidney disease (CKD) on dialysis with hyperphosphatemia. The study was designed to evaluate different methods of ...
KRDO5d
The job market is ‘frozen.’ That’s not a good sign for DOGE casualties
The Trump administration’s culling of government programs and agencies has resulted in an unprecedented wave of ...